COM:NGMBIO
NGM Bio
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.ngmbio.comlinkedin
ngm-biopharmaceuticalsfounding date
Jan 01, 2007ipo date
Apr 04, 2019
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trials for the treatment of non-alcoho...Show More